Viewing Study NCT07223203


Ignite Creation Date: 2025-12-24 @ 7:48 PM
Ignite Modification Date: 2026-01-17 @ 1:55 AM
Study NCT ID: NCT07223203
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-22
First Post: 2025-10-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
Sponsor: Alnylam Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module